The aim of work is to determine spread of HGV antibodies among haemodialytic patients by ELISA and its relation to other hepatitis viruses. 50 patients suffering from chronic renal failure and on haemodialysis for at least 12 months were selected as cases and 20 apparently healthy persons were selected as control. cases were divided into 2 groups: Group I (30 patients) with history of repeated blood transfusion and Group II (20 patients) have no history of blood transfusion. Results: 22 %( 11/50) of patients were positive to HGV antibodies (group I 30 % 9/30 and group II 10% 2/20) and one case only 5% from the control group. From the 11patients who were HGV positive, 9 (81.8%) had history of blood transfusion, 2 (18.2%) were positive for HBsAg, 9 (81.8%) were positive for HCV antibodies but 5 of them were positive by PCR. Conclusion : In spite of HGV could be present alone without other hepatitis viruses and has no effect on liver functions , haemodialytic patients are more susceptible to acquire HGV infection and blood transfusion play an important role in its transmission .